European Medical Association
European Medical Association (EMA) is a non-profit, non-governmental organisation that represents the interests of medical professionals, healthcare providers, and patients in Europe. The EMA is responsible for the scientific evaluation, supervision, and safety monitoring of medicines in the EU.
History[edit]
The European Medical Association was established in 1995 with the aim of enhancing the medical profession in Europe and promoting the highest standards of medical ethics and medical education.
Role and Responsibilities[edit]
The EMA's primary role is to facilitate the development and access to medicines. It does this by assessing the quality, safety, and efficacy of medicines, and authorising their marketing in the EU. The EMA also monitors the safety of medicines throughout their lifecycle and provides information to healthcare professionals and patients.
Structure[edit]
The EMA is governed by a Management Board, which is responsible for ensuring that the Agency functions efficiently and effectively. The Board is composed of representatives from EU Member States, the European Commission, and patient, doctor, and nurse organisations.
Activities[edit]
The EMA carries out a wide range of activities, including:
- Scientific evaluation of medicines
- Safety monitoring and risk management of medicines
- Providing information to healthcare professionals and patients
- Promoting research and development in the field of medicines
Criticism and Controversy[edit]
The EMA has faced criticism for its perceived lack of transparency and potential conflicts of interest. However, the Agency has taken steps to address these concerns, including implementing stricter rules on declarations of interest and increasing the transparency of its decision-making processes.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian